| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Werewolf Therapeutics (NASDAQ:HOWL) reported its Q4 earnings results on Thursday, March 7, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Werewolf Therapeutics beat estimated earnings by 23.0%, reporting an EPS of $-0.33 versus an estimate of $-0.43.
Revenue was down $5.78 million from the same period last year.
Last quarter the company beat on EPS by $0.16 which was followed by a 0.0% increase in the share price the next day.
Here's a look at Werewolf Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.39 | -0.42 | -0.50 | -0.55 |
| EPS Actual | -0.23 | -0.14 | -0.34 | -0.39 |
| Revenue Estimate | 1.59M | 2.46M | 5.00M | 2.07M |
| Revenue Actual | 5.90M | 8.08M | 4.46M | 7.28M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Werewolf Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: HOWL
